Skip to main content
Avid Bioservices, Inc. (CDMO)
Feb 5, 2025 - CDMO was delisted (reason: acquired by GHO & Ampersand)
12.49
0.00 (0.00%)
Inactive · Last trade price on Feb 4, 2025

Avid Bioservices Revenue

Avid Bioservices had revenue of $33.48M in the quarter ending October 31, 2024, with 31.84% growth. This brings the company's revenue in the last twelve months to $150.45M, up 6.75% year-over-year. In the fiscal year ending April 30, 2024, Avid Bioservices had annual revenue of $139.91M, down -6.27%.

Revenue (ttm)
$150.45M
Revenue Growth
+6.75%
P/S Ratio
5.28
Revenue / Employee
$405,512
Employees
371
Market Cap
798.90M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 2024139.91M-9.36M-6.27%
Apr 30, 2023149.27M29.67M24.81%
Apr 30, 2022119.60M23.73M24.75%
Apr 30, 202195.87M36.17M60.58%
Apr 30, 202059.70M6.10M11.38%
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CDMO News

More News